.Property manager TPG, which has sustained biotechs such as Sionna Therapies as well as Santa Ana Bi...
.Merck & Co.'s TIGIT system has actually gone through yet another trouble. Months after shutterin...
.After a year defined by pipe hairstyles, the departure of its own CEO and layoffs, Exscientia will ...
.Cullinan Therapy was actually thrilled sufficient along with Port BioMed's bispecific immune system...
.Within this full week's episode of "The Top Line," our experts're diving into Strong Biotech's annu...
.The confetti is actually still soaring coming from Eli Lilly's celebration commemorating the approv...
.Accept to today's Chutes & Ladders, our roundup of considerable management hirings, shootings as...
.Complying with an unsatisfactory presenting for Lykos Rehabs' MDMA prospect for trauma at a latest ...
.AN2 Rehabs is actually reassessing its own service in feedback to lackluster midphase data, pledgin...
.Merck & Co. is paying $700 million upfront to test Amgen in a blood cancer cells market. The dea...